Pharma BD Deal Intelligence
Jazz Pharmaceuticals PLC / GW Pharmaceuticals
2021 · Acquisition/Merger · $7.2B · Complete
Announcement Sentiment
80
Strongly positive
Outcome Score
77
Worked — the deal delivered on its rationale.
Jazz acquired GW Pharmaceuticals for $7.2B for Epidiolex (cannabidiol) for epilepsy.
Key facts
- Announced Feb 03, 2021
- Closed May 05, 2021
- Deal value $7.2B
- Deal type Acquisition/Merger
- Therapeutic area Neurology
- Key assets Epidiolex
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals